These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 2819654

  • 1. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
    Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N.
    Cancer; 1989 Dec 15; 64(12):2448-58. PubMed ID: 2819654
    [Abstract] [Full Text] [Related]

  • 2. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
    Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC.
    J Urol; 1985 Mar 15; 133(3):403-7. PubMed ID: 4038749
    [Abstract] [Full Text] [Related]

  • 3. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.
    Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, Weiselberg LR.
    J Urol; 1988 Mar 15; 139(3):461-9. PubMed ID: 3343727
    [Abstract] [Full Text] [Related]

  • 4. The effect of dose intensity on M-VAC therapy for advanced urothelial cancer.
    Miyanaga N, Akaza H, Shimazui T, Ohtani M, Koiso K.
    Cancer Chemother Pharmacol; 1994 Mar 15; 35 Suppl():S5-8. PubMed ID: 7527735
    [Abstract] [Full Text] [Related]

  • 5. [Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer].
    Sella A, Flex D, Gafni D, Rabinovitz O, Sulkes A, Baniel J.
    Harefuah; 1999 Feb 15; 136(4):268-71, 340, 339. PubMed ID: 10914214
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) for advanced TCC of urothelium.
    Huang CH, Hsieh HH, Wang JM, Hsu K, Yang WC, Yu TJ.
    J Formos Med Assoc; 1992 Jul 15; 91(7):699-703. PubMed ID: 1360298
    [Abstract] [Full Text] [Related]

  • 7. Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.
    Dodd PM, McCaffrey JA, Mazumdar M, Scher H, Vlamis V, Higgins G, Herr H, Bajorin DF.
    Cancer; 1999 Mar 01; 85(5):1145-50. PubMed ID: 10091800
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapy of urothelial tract tumors.
    Yagoda A.
    Cancer; 1987 Aug 01; 60(3 Suppl):574-85. PubMed ID: 3297286
    [Abstract] [Full Text] [Related]

  • 9. Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
    Kobayashi H, Obata K.
    Cancer Chemother Pharmacol; 1994 Aug 01; 35 Suppl():S14-7. PubMed ID: 7994781
    [Abstract] [Full Text] [Related]

  • 10. [Methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer--analysis of efficacy and toxicity].
    Igawa M, Kadena H, Ohkuchi T, Ueda M, Usui T.
    Nihon Hinyokika Gakkai Zasshi; 1991 Oct 01; 82(10):1627-36. PubMed ID: 1770701
    [Abstract] [Full Text] [Related]

  • 11. CMV chemotherapy for advanced transitional cell carcinoma.
    Jeffery GM, Mead GM.
    Br J Cancer; 1992 Sep 01; 66(3):542-6. PubMed ID: 1520591
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.
    Scher HI, Yagoda A, Herr HW, Sternberg CN, Morse MJ, Sogani PC, Watson RC, Reuter V, Whitmore WF, Fair WR.
    J Urol; 1988 Mar 01; 139(3):475-7. PubMed ID: 3343729
    [Abstract] [Full Text] [Related]

  • 13. Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract.
    Lerner SE, Blute ML, Richardson RL, Zincke H.
    Mayo Clin Proc; 1996 Oct 01; 71(10):945-50. PubMed ID: 8820768
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin-based chemotherapy for the treatment of advanced transitional-cell carcinoma of the urinary tract--a preliminary report.
    Lee MH, Chen MT, Chen KK, Lin AT, Lee YH, Lee LM, Chang YM, Chang LS, Liu JM, Hsieh RK.
    Cancer Chemother Pharmacol; 1992 Oct 01; 30 Suppl():S81-4. PubMed ID: 1394825
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced urothelial cancer.
    Ueki O, Hisazumi H, Uchibayashi T, Naito K, Tajiri S, Takemae K, Kawaguchi K, Kameda K, Nishino A, Nango C.
    Cancer Chemother Pharmacol; 1992 Oct 01; 30 Suppl():S72-6. PubMed ID: 1394823
    [Abstract] [Full Text] [Related]

  • 16. Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder.
    Miller RJ, Bahnson RR, Banner B, Ernstoff MS, O'Donnell WF.
    Cancer; 1990 Jan 15; 65(2):207-10. PubMed ID: 2295043
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concern.
    Connor JP, Olsson CA, Benson MC, Rapoport F, Sawczuk IS.
    Urology; 1989 Dec 15; 34(6):353-6. PubMed ID: 2595880
    [Abstract] [Full Text] [Related]

  • 18. [M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma].
    Igawa M, Ueki T, Ueda M, Okada K, Usui T, Ohnishi Y, Kume T, Masu C, Ishino T, Nakatsu H.
    Gan To Kagaku Ryoho; 1989 Aug 15; 16(8 Pt 1):2577-82. PubMed ID: 2673046
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    Kyriakakis Z, Dimopoulos MA, Kostakopoulos A, Karayiannis A, Sofras F, Zervas A, Giannopoulos A, Dimopoulos C.
    J Urol; 1997 Aug 15; 158(2):408-11. PubMed ID: 9224313
    [Abstract] [Full Text] [Related]

  • 20. Usefulness and limitations of methotrexate, vinblastine, doxorubicin and cisplatin for the treatment of advanced urothelial cancer.
    Igawa M, Ohkuchi T, Ueki T, Ueda M, Okada K, Usui T.
    J Urol; 1990 Sep 15; 144(3):662-5. PubMed ID: 2388322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.